aca24@aca-pharma.de/ +49 341 223 292 36

Updated ECHA Q&A document on the restriction of Cr(VI) substances is available

Kommentare deaktiviert für Updated ECHA Q&A document on the restriction of Cr(VI) substances is available

What impact will the entry into force of the restriction have on existing authorizations? News

Comments are closed.